Stay updated with breaking news from Codex Dna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Codex DNA (NASDAQ:DNAY – Get Rating) issued its quarterly earnings results on Tuesday. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.06), MarketWatch Earnings reports. Codex DNA updated its FY 2022 guidance to EPS. DNAY traded down $0.76 on Thursday, hitting $5.30. 1,160,977 shares of […]
SAN DIEGO, March 02, 2022 -- Codex DNA, Inc. , a pioneer in automated benchtop synthetic biology systems, today announced that it will release its fourth quarter 2021 financial results on Tuesday,... | March 2, 2022
Codex DNA Announces Pricing of Initial Public Offering June 17, 2021 22:16 ET | Source: Codex DNA, Inc. Codex DNA, Inc. San Diego, California, UNITED STATES SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (“Codex DNA”), creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today announced the pricing of its initial public offering of 6,666,665 shares of its common stock at a public offering price of $16.00 per share. All of the shares are being offered by Codex DN...